Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2025-12-25 @ 12:35 AM
NCT ID: NCT00902967
Eligibility Criteria: Inclusion Criteria: 1. Male or female patients aged 25-55 years 2. Patients who will be undergoing abdominal surgery under spinal anaesthesia 3. Patients who will undergo non-bowel abdominal surgery with an abdominal incision 4. Understands and agrees to comply with all study procedures including the daily treatments and follow-up visits 5. Able to understand and is voluntarily willing to sign an informed consent form for this study 6. Weight between 50 and 120 kg Exclusion Criteria: 1. Bowel surgery or surgery under general anaesthesia 2. Any emergency operations 3. Surgery in patients in whom the chances of infection are very high. Example peritonitis, cystitis, appendical abscess, perforations, etc 4. Laparoscopic Surgery 5. Pregnant or nursing, or with the ability to become pregnant and not using an accepted form of birth control 6. Any active Cancer 7. Uncontrolled diabetes mellitis 8. Untreated hypertension 9. Psychotic disorder(s), dementia, mental retardation, or other organic mental disorders (subjects who are not mentally and physically able to personally consent for participation in this study are not eligible) 10. Any other (including acute) condition, which in the opinion of the investigator, is likely to cause non-compliance or significantly impact treatment outcomes 11. Sensitivity to the study drug or its components
Healthy Volunteers: False
Sex: ALL
Minimum Age: 25 Years
Maximum Age: 55 Years
Study: NCT00902967
Study Brief:
Protocol Section: NCT00902967